Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



Multi-country cross-sectional study of colonization with multidrug-resistant organisms: protocol and methods for the Antibiotic Resistance in Communities and Hospitals (ARCH) studies
Indexado
WoS WOS:000675238000009
Scopus SCOPUS_ID:85110554466
DOI 10.1186/S12889-021-11451-Y
Año 2021
Tipo artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



BackgroundAntimicrobial resistance is a global health emergency. Persons colonized with multidrug-resistant organisms (MDROs) are at risk for developing subsequent multidrug-resistant infections, as colonization represents an important precursor to invasive infection. Despite reports documenting the worldwide dissemination of MDROs, fundamental questions remain regarding the burden of resistance, metrics to measure prevalence, and determinants of spread. We describe a multi-site colonization survey protocol that aims to quantify the population-based prevalence and associated risk factors for colonization with high-threat MDROs among community dwelling participants and patients admitted to hospitals within a defined population-catchment area.MethodsResearchers in five countries (Bangladesh, Chile, Guatemala, Kenya, and India) will conduct a cross-sectional, population-based prevalence survey consisting of a risk factor questionnaire and collection of specimens to evaluate colonization with three high-threat MDROs: extended-spectrum cephalosporin-resistant Enterobacteriaceae (ESCrE), carbapenem-resistant Enterobacteriaceae (CRE), and methicillin-resistant Staphylococcus aureus (MRSA). Healthy adults residing in a household within the sampling area will be enrolled in addition to eligible hospitalized adults. Colonizing isolates of these MDROs will be compared by multilocus sequence typing (MLST) to routinely collected invasive clinical isolates, where available, to determine potential pathogenicity. A colonizing MDRO isolate will be categorized as potentially pathogenic if the MLST pattern of the colonizing isolate matches the MLST pattern of an invasive clinical isolate. The outcomes of this study will be estimates of the population-based prevalence of colonization with ESCrE, CRE, and MRSA; determination of the proportion of colonizing ESCrE, CRE, and MRSA with pathogenic characteristics based on MLST; identification of factors independently associated with ESCrE, CRE, and MRSA colonization; and creation an archive of ESCrE, CRE, and MRSA isolates for future study.DiscussionThis is the first study to use a common protocol to evaluate population-based prevalence and risk factors associated with MDRO colonization among community-dwelling and hospitalized adults in multiple countries with diverse epidemiological conditions, including low- and middle-income settings. The results will be used to better describe the global epidemiology of MDROs and guide the development of mitigation strategies in both community and healthcare settings. These standardized baseline surveys can also inform future studies seeking to further characterize MDRO epidemiology globally.

Revista



Revista ISSN
Bmc Public Health 1471-2458

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Public, Environmental & Occupational Health
Scopus
Sin Disciplinas
SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 Sharma, Aditya Hombre US Ctr Dis Control & Prevent - Estados Unidos
National Center for Emerging and Zoonotic Infectious Diseases - Estados Unidos
2 Luvsansharav, Ulzii-Orishikh - US Ctr Dis Control & Prevent - Estados Unidos
National Center for Emerging and Zoonotic Infectious Diseases - Estados Unidos
3 Paul, Prabasaj - US Ctr Dis Control & Prevent - Estados Unidos
National Center for Emerging and Zoonotic Infectious Diseases - Estados Unidos
4 Lutgring, Joseph D. Hombre US Ctr Dis Control & Prevent - Estados Unidos
National Center for Emerging and Zoonotic Infectious Diseases - Estados Unidos
5 Call, Douglas R. Hombre WASHINGTON STATE UNIV - Estados Unidos
Washington State University Pullman - Estados Unidos
6 Omulo, Sylvia Mujer WASHINGTON STATE UNIV - Estados Unidos
Washington State University Pullman - Estados Unidos
7 Laserson, Kayla Mujer US Ctr Dis Control & Prevent - Estados Unidos
National Center for Emerging and Zoonotic Infectious Diseases - Estados Unidos
8 ARAOS-BRALIC, RAFAEL IGNACIO Hombre Universidad del Desarrollo - Chile
Millennium Initiat Collaborat Res Bacterial Resis - Chile
Núcleo Milenio para la Investigación Colaborativa en Resistencia Antimicrobiana - Chile
9 MUNITA-SEPULVEDA, JOSE MANUEL Hombre Universidad del Desarrollo - Chile
Millennium Initiat Collaborat Res Bacterial Resis - Chile
Núcleo Milenio para la Investigación Colaborativa en Resistencia Antimicrobiana - Chile
10 Verani, Jennifer Mujer KEMRI Complex - Kenia
Kenya Medical Research Institute - Kenia
11 Chowdhury, Fahmida - Icddr B - Bangladesh
International Centre for Diarrhoeal Disease Research Bangladesh - Bangladesh
12 Muneer, Syeda Mah-E Mujer Icddr B - Bangladesh
International Centre for Diarrhoeal Disease Research Bangladesh - Bangladesh
13 Espinosa-Bode, Andres Hombre Interior Univ Valle - Guatemala
Universidad del Valle - Guatemala
14 Ramay, Brooke Mujer WASHINGTON STATE UNIV - Estados Unidos
Univ Valle Guatemala - Guatemala
Washington State University Pullman - Estados Unidos
UNIVERSIDAD DEL VALLE DE GUATEMALA - Guatemala
15 Cordon-Rosales, Celia Mujer Univ Valle Guatemala - Guatemala
UNIVERSIDAD DEL VALLE DE GUATEMALA - Guatemala
16 Kumar, C. P. Girish - Natl Inst Epidemiol - India
National Institute of Epidemiology - India
17 Bhatnagar, Tarun Hombre Natl Inst Epidemiol - India
National Institute of Epidemiology - India
18 Gupta, Neil Hombre US Ctr Dis Control & Prevent - Estados Unidos
National Center for Emerging and Zoonotic Infectious Diseases - Estados Unidos
19 Park, Benjamin Hombre US Ctr Dis Control & Prevent - Estados Unidos
National Center for Emerging and Zoonotic Infectious Diseases - Estados Unidos
20 Smith, Rachel M. Mujer US Ctr Dis Control & Prevent - Estados Unidos
KEMRI Complex - Kenia
Interior Univ Valle - Guatemala
National Center for Emerging and Zoonotic Infectious Diseases - Estados Unidos
Kenya Medical Research Institute - Kenia
Universidad del Valle - Guatemala

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento



Fuente
Centers for Disease Control and Prevention
U.S. Centers for Disease Control and Prevention (CDC) via Global Health Security Agenda
Broad Agency Announcement contract
Broad Agency

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
This work was supported by the U.S. Centers for Disease Control and Prevention (CDC) via Global Health Security Agenda cooperative agreements (GH001859, GH001207, GH002143, and GH002241) and a Broad Agency Announcement contract (#75D301-18C-02925). Authors with a CDC affiliation were employed by U.S. CDC at the time when this study was conceived, and the protocol was written. These CDC-employed authors contributed to the study as detailed below in Authors' contributions. Apart from these CDCemployed author contributions, the funder had no other role in the study.
This work was supported by the U.S. Centers for Disease Control and Prevention (CDC) via Global Health Security Agenda cooperative agreements (GH001859, GH001207, GH002143, and GH002241) and a Broad Agency Announcement contract (#75D301-18C-02925). Authors with a CDC affiliation were employed by U.S. CDC at the time when this study was conceived, and the protocol was written. These CDC-employed authors contributed to the study as detailed below in Authors’ contributions. Apart from these CDC-employed author contributions, the funder had no other role in the study.

Muestra la fuente de financiamiento declarada en la publicación.